---
document_datetime: 2024-02-26 16:31:25
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/memantine-merz-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: memantine-merz-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.1507937
conversion_datetime: 2025-12-24 22:39:45.383579
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Memantine Merz

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0021               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                             | 16/02/2024                          |                                             | Labelling and PL                 |           |
| WS/2413/G            | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No | 25/05/2023                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | 1234/2008. B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IG/1597/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place A.7 - Administrative change - Deletion of | 03/03/2023 | n/a |

<div style=\"page-break-after: always\"></div>

|                    | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                          |            |            |                        |                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| WS/1980            | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                           | 18/03/2021 | 04/04/2022 | SmPC, Labelling and PL |                                   |
| WS/1579            | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.II.e.1.a.2 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Semi-solid and non-sterile liquid pharmaceutical forms | 29/05/2019 | 12/06/2020 | SmPC and PL            |                                   |
| PSUSA/1967/ 201809 | Periodic Safety Update EU Single assessment - memantine                                                                                                                                                                                                                                                                | 16/05/2019 | n/a        |                        | PRAC Recommendation - maintenance |
| IG/0835/G          | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting                                                                                                                                                                                 | 13/09/2017 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate/reagent - Tightening of specification limits B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                       |            |            |                                  |                                                                                                                                                                                                                                                                              |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0012    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 18/05/2017 | 13/07/2017 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Memantine Merz in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IG/0768/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 06/03/2017 | n/a        |                                  |                                                                                                                                                                                                                                                                              |
| IG/0767   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                    | 06/03/2017 | n/a        |                                  |                                                                                                                                                                                                                                                                              |
| N/0011    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                 | 23/01/2017 | 13/07/2017 | PL                               |                                                                                                                                                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

| PSUSA/1967/ 201509   | Periodic Safety Update EU Single assessment - memantine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 14/04/2016   | n/a        |    | PRAC Recommendation - maintenance   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----|-------------------------------------|
| WS/0804              | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                                                                                | 25/02/2016   | n/a        |    |                                     |
| N/0009               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 01/12/2015   | 13/07/2017 | PL |                                     |
| N/0007               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 29/07/2015   | 13/07/2017 | PL |                                     |
| WS/0668              | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Following new data lock point, interim results of the Prostate Cancer study, 4 finalized studies and reformatting in compliance with the new template, submission of a revised and updated RMP version 7.1 (delete). This RMP update also introduces changes to the required additional Pharmacovigilance activity regarding the identified potential risk of prostate cancer by adjusting the due dates of agreed milestones. The final RMP version is 7.2. | 23/04/2015   | n/a        |    |                                     |

<div style=\"page-break-after: always\"></div>

|                    | C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required                                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |                                  |                                   |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| PSUSA/1967/ 201409 | Periodic Safety Update EU Single assessment - memantine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 10/04/2015 | n/a        |                                  | PRAC Recommendation - maintenance |
| IAIN/0006          | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 02/02/2015 | n/a        |                                  |                                   |
| WS/0562            | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. Update of section 4.6 of the SmPC for Axura and Memantine Merz with information currently included in section 5.3 referring to the absence of adverse effects noted on non-clinical male and female fertility studies, as per the QRD template. In addition, all the annexes have been brought in line with the QRD template version 9 and linguistic amendments have been introduced in some translations, including a correction of the list of excipients for Iron oxide in the German version. The Croatian local representative has also been included in the package | 25/04/2014 | 13/05/2015 | SmPC, Annex II, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

|                    | leaflet. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation   |            |     |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/1967/ 201309 | Periodic Safety Update EU Single assessment - memantine                                                   | 10/04/2014 | n/a | PRAC Recommendation - maintenance |
| IG/0260            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation            | 25/01/2013 | n/a |                                   |